News

Filter

Current filters:

Neumega

1 to 9 of 97522 results

Innovation and confidence at JP Morgan conference, says Edison analyst

26-01-2015

The atmosphere at this year's annual JPMorgan Conference in San Francisco was understandably buoyant,…

BiotechnologyFinancialMergers & AcquisitionsResearch

CIPA and KEFEA discuss initiatives to improve Cyprus’ pharma investment climate

26-01-2015

The potential to attract investments in the pharmaceutical industry and develop joint initiatives to…

FinancialHealthcarePharmaceuticalRest of the World

Kite Pharma expands CAR-T deal with Sourasky Medical Center

26-01-2015

US clinical-stage biopharma company Kite Pharma, focused on developing engineered autologous T cell therapy…

BiotechnologyKite PharmaOncologyResearch

Gilead expands hepatitis C agreements to include sofosbuvir/GS-5816 single tablet regimen

Gilead expands hepatitis C agreements to include sofosbuvir/GS-5816 single tablet regimen

26-01-2015

US biotech major Gilead Sciences has expanded its hepatitis C generic licensing agreements to include…

Anti-viralsBiotechnologyGenericsGilead SciencesIndiaLicensingSovaldiUSA

Nicox holds successful pre-NDA meeting with FDA for AC-170

Nicox holds successful pre-NDA meeting with FDA for AC-170

26-01-2015

French ophthalmics company Nicox has held a positive pre-New Drug Application meeting with the US Food…

AC-170NicOxOphthalmicsPharmaceuticalRegulationUSA

ALK's partner Torii submits NDA in Japan for house dust mite sublingual tablet

ALK's partner Torii submits NDA in Japan for house dust mite sublingual tablet

26-01-2015

Denmark-based allergy specialist ALK Abello’s Japanese partner, Torii Pharmaceutical, has submitted…

ALK AbelloImmunologicalsJapanPharmaceuticalRegulationSLIT-tabletTorii Pharma

Ipsen's Dysport gives positive results in adult and pediatric lower limb spasticity

Ipsen's Dysport gives positive results in adult and pediatric lower limb spasticity

26-01-2015

French drugmaker Ipsen has announced top line results from two double-blind Phase III trials of Dysport…

CNS DiseasesDysportFranceIpsenPharmaceuticalResearch

1 to 9 of 97522 results

Back to top